GRACEcast - Emerging Molecular Targets in NSCLC- MET with Dr. Josh Bauml

from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE

Dr. Josh Bauml, member of the GRACE faculty, discusses emerging molecular targets in non small cell lung cancer with a MET mutation. for more information visit www.cancerGRACE.org

Episode metadata supplied by the publisher feed · Published Oct 7, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

GRACEcast - Emerging Molecular Targets in NSCLC- MET with Dr. Josh Bauml

0:00 7:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?

This episode is 7 minutes long.

When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?

This episode was published on October 7, 2020.

Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!